SCHEMBL10282910

SCHEMBL10282910

CC(C)(C)OC(=O)N1CCC(C=O)(c2ccncc2)CC1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 5/20 0.45
OPRD1 P41143 1/20 0.43
OPRK1 P41145 1/20 0.43
NAMPT P43490 6/20 0.43
CYP2C9 P11712 1/20 0.43
HIF1A Q16665 1/20 0.42
JAK2 O60674 1/20 0.42
JAK1 P23458 1/20 0.42
POLB P06746 1/20 0.42
TSHR P16473 2/20 0.42
ALOX15 P16050 1/20 0.42
ATM Q13315 1/20 0.42
CYP11B2 P19099 1/20 0.41
PDE4A P27815 1/20 0.41
PDE4B Q07343 1/20 0.41
PDE4C Q08493 1/20 0.41
PDE4D Q08499 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL442118 0.87 TSHR (0.54) GPR119OPRD1OPRK1TSHRALOX15
SCHEMBL702268 0.85 GPR119 (0.52) GPR119OPRD1OPRK1NAMPTJAK2
SCHEMBL1001982 0.85 MEN1 (0.53) POLBTSHRALOX15ATM
SCHEMBL14541563 0.85 RORC (0.48) JAK2JAK1TSHRALOX15ATM
SCHEMBL25458288 0.83 GPR119 (0.50) GPR119OPRD1OPRK1NAMPTCYP2C9
SCHEMBL16565419 0.82 GPR119 (0.53) GPR119OPRD1OPRK1TSHRALOX15
SCHEMBL10282908 0.82 GPR119 (0.41) GPR119OPRD1OPRK1NAMPTCYP2C9
SCHEMBL23647585 0.82 JAK2 (0.48) GPR119OPRD1OPRK1NAMPTCYP2C9
SCHEMBL16554218 0.81 ATM (0.44) GPR119OPRD1OPRK1TSHRALOX15
SCHEMBL8352820 0.81 TSHR (0.53) GPR119OPRD1OPRK1NAMPTCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8124624-B2 Substituted sulfonamide compounds GRUENENTHAL GMBH (DE) 2012-02-28 US disclosed
US-20090264407-A1 Substituted Sulfonamide Compounds GRUENENTHAL GMBH (DE) 2009-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090264407-A1 Substituted Sulfonamide Compounds CNR1, SUCNR1, OPRL1 GPR119 98/4885OPRD1 28/4885OPRK1 13/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.